UnknownPhase 4

Elmex Gel Efficacy in Preventing White Spot Lesions

Germany, Israel314 participantsStarted 2006-04

Plain-language summary

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Who can participate

Age range10 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * treatment plan: minimum of 10 teeth to be bonded labially at least 10 years old * written declaration of informed consent Exclusion Criteria: * known allergy to components of test products * handicapped patients who have difficulties brushing their teeth * pathological desquamation changes * known pregnancy, breast feeding * eating disorders * disease that effect dental hard tissue * participation in another clinical trial either currently or within the lase 30 days

What they're measuring

time and frequency of visually detected WSL (white spot lesions)

Timeframe: 3 month

Trial details

NCT IDNCT00268138

SponsorHadassah Medical Organization

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-12

Contact for this trial

Andrea Engl, Dr.

++41614156056 a.engl@gaba.com

View on ClinicalTrials.gov More Dental Caries trials